Bhutan vs Western Pacific (WHO region): Measles-containing-vaccine second-dose (MCV2) immunization coverage
Bhutan
99.0%
in 2025
Western Pacific (WHO region)
86.0%
in 2025
Bhutan rank
1st
Western Pacific (WHO region) rank
4th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Bhutan
- Western Pacific (WHO region)
How they compare
Bhutan currently reports 99.0% against 86.0% in Western Pacific (WHO region), a difference of 13.0%.
That makes Bhutan's figure about 1.2 times Western Pacific (WHO region)'s.
The two have swapped places 3 times across 26 shared years of data; in 2000 it was Western Pacific (WHO region) ahead.
Bhutan ranks 1st and Western Pacific (WHO region) ranks 4th of 194 countries.
Across the 3 decades both report, Bhutan averaged higher in 2 and Western Pacific (WHO region) in 1.
Head to head by decade
| Decade | Bhutan | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15.1% | 37.8% | 22.7% | Western Pacific (WHO region) |
| 2010s | 91.7% | 86.7% | 5.0% | Bhutan |
| 2020s | 95.3% | 86.7% | 8.7% | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Bhutan or Western Pacific (WHO region)?
- Bhutan, at 99.0% against 86.0% in Western Pacific (WHO region) as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Bhutan and Western Pacific (WHO region)?
- 13.0%, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Western Pacific (WHO region)?
- 26 years are reported by both, from 2000 to 2025.
- How do Bhutan and Western Pacific (WHO region) rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Bhutan ranks 1st and Western Pacific (WHO region) ranks 4th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.